BIO Professional Development
Through a curated network of education alliance partners, BIO offers industry professionals executive training and development resources for accelerating career growth
06/02/2024 - 06/02/2024 | 9:00 AM - 5:00 PM EDT
Product & Company Valuation
The "Product & Company Valuation" course is designed to teach a systematic approach to producing a valuation that can be used in investment rounds, mergers/acquisitions, licensing deals, or strategic development decisions in the pharma-biotech world.
This introductory course is very valuable for pharma and biotech executives who are not familiar with compound and company valuations but need a thorough understanding of the valuation concepts and techniques that are commonly applied in the pharma and biotech industries. It goes beyond the number-crunching techniques of most consultants and includes difficult to define qualitative factors, which shape the risk profile of the company in question. This course optimally balances interactive lectures with practical group work exercises that are designed to help you practice the fundamental valuation tools & techniques taught throughout the day.
Valuation is an inherently subjective task, which is made even more difficult in the life science industry due to its unique challenges: high attrition rates in R&D, long investment cycle, complex technologies, IP situations, etc. Therefore, traditional valuation methods are not suitable. Of particular value in this course is the “Product Valuation and Deal Structuring” module where registrants will learn the commonly used rNPV (i.e., risk-adjusted Net Present Value) method for calculating the value of a drug in development. Subsequently, you will practice how to structure a licensing deal between companies. Registrants will use an Excel-based tool designed specifically for this module, which can be taken home for future use.
Topics covered in the Product & Company Valuation course include:
- Introduction to valuation
- Assessing a company prior to valuation
- Company valuation and methods
- Product valuation and methods
- Deal structuring
This one-day course will be held in person on June 2, 2024, in San Diego, Calif. Registration opens on January 23, 2024.
Interested in only registering for an in-person course in San Diego? For course-only registration instructions, email: courseshelp@bio.org
Instructors (click photo to view bios)
Takeaways
- Determine the assessment/value drivers
- Explore main valuation approaches, tools, and techniques
- Learn how to value a company
- Understand how to value an individual product
Download Course Syllabus
Certificate Requirements
- Attend the entire in-person course
- Complete course evaluation within two weeks of the course end date
Learn the most effective strategies for approaching institutional investors for a Series B or later...
Gain the commercialization knowledge CEOS need to strategically position their organizations for financing success and meeting critical milestones.
A digital strategy can no longer lie within a siloed digital or innovation team. It’s critical to integrate digital across the enterprise to maintain a competitive edge.
A good regulatory strategy is essential to a good business strategy.
